tradingkey.logo

Galectin Therapeutics Inc <GALT.OQ> expected to post a loss of 20 cents a share - Earnings Preview

ReutersMay 14, 2025 2:18 PM
  • Galectin Therapeutics Inc GALT.OQ GALT.O is expected to report results on May 16 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Galectin Therapeutics Inc is for a loss of 20 cents per share.

  • The one available analyst rating on the shares is "hold".

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

This summary was machine generated May 14 at 14:18 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI